Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of …

L Liu, W Chen, H Zhou, W Duan, S Li, X Huo… - Stroke and vascular …, 2020 - svn.bmj.com
Aim Stroke is the leading cause of disability and death in China. Ischaemic stroke accounts
for about 60%–80% of all strokes. It is of considerable significance to carry out …

Trial of endovascular therapy for acute ischemic stroke with large infarct

X Huo, G Ma, X Tong, X Zhang, Y Pan… - … England Journal of …, 2023 - Mass Medical Soc
Background The role of endovascular therapy for acute stroke with a large infarction has not
been extensively studied in differing populations. Methods We conducted a multicenter …

Platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban in acute ischemic stroke

M Yang, X Huo, Z Miao, Y Wang - Drugs, 2019 - Springer
Tirofiban is a non-peptide selective glycoprotein (GP) IIb/IIIa receptor inhibitor that reversibly
inhibits fibrinogen-dependent platelet aggregation and subsequent formation of thrombi …

Endovascular thrombectomy for anterior circulation large vessel occlusion stroke: an evolution of trials

N Starikova, S Räty, D Strbian, DPO Kaiser… - Seminars in …, 2023 - thieme-connect.com
The last decade's progress in demonstrating the clinical benefit of endovascular
thrombectomy (EVT) in patients with large vessel occlusion stroke has transformed the …

Mechanical thrombectomy and rescue therapy for intracranial large artery occlusion with underlying atherosclerosis

BX Jia, L Feng, DS Liebeskind, X Huo, F Gao… - Journal of …, 2018 - jnis.bmj.com
Objective To investigate the safety and efficacy of mechanical thrombectomy plus rescue
therapy for intracranial large artery occlusion (ILAO) with underlying intracranial …

Current status of endovascular treatment for acute large vessel occlusion in China: a real-world nationwide registry

B Jia, Z Ren, M Mokin, WS Burgin, CT Bauer, J Fiehler… - Stroke, 2021 - Am Heart Assoc
Background and Purpose: The benefit of endovascular treatment (EVT) for large vessel
occlusion in clinical practice in developing countries like China needs to be confirmed. The …

Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial

B Jia, X Zhang, N Ma, D Mo, F Gao, X Sun… - JAMA …, 2022 - jamanetwork.com
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …

[HTML][HTML] Exosomes derived from microRNA-138-5p-overexpressing bone marrow-derived mesenchymal stem cells confer neuroprotection to astrocytes following …

Y Deng, D Chen, F Gao, H Lv, G Zhang, X Sun… - Journal of biological …, 2019 - Springer
Background MicroRNAs (miRNAs) are implicated in the progression of ischemic stroke (IS)
and bone marrow-derived mesenchymal stem cells (BMSCs)-derived exosomes play a role …

Efficacy and safety of butylphthalide in patients with acute ischemic stroke: a randomized clinical trial

A Wang, B Jia, X Zhang, X Huo, J Chen, L Gui… - JAMA …, 2023 - jamanetwork.com
Importance DL-3-n-butylphthalide (NBP) is a drug for treating acute ischemic stroke and may
play a neuroprotective role by acting on multiple active targets. The efficacy of NBP in …

Mechanical thrombectomy global access for stroke (MT-GLASS): a mission thrombectomy (MT-2020 Plus) study

KS Asif, FO Otite, SM Desai, N Herial, V Inoa… - Circulation, 2023 - Am Heart Assoc
Background: Despite the well-established potent benefit of mechanical thrombectomy (MT)
for large vessel occlusion (LVO) stroke, access to MT has not been studied globally. We …